Literature DB >> 15770733

Hypoxia-inducible factor 1 alpha and vascular endothelial growth factor overexpression in ischemic colitis.

Tomoyuki Okuda1, Takeshi Azuma, Masahiro Ohtani, Ryuho Masaki, Yoshiyuki Ito, Yukinao Yamazaki, Shigeji Ito, Masaru Kuriyama.   

Abstract

AIM: To examine the etiology and pathophysiology in human ischemic colitis from the viewpoint of ischemic factors such as hypoxia-inducible factor 1 alpha (HIF-1 alpha and vascular endothelial growth factor (VEGF).
METHODS: Thirteen patients with ischemic colitis and 21 normal controls underwent colonoscopy. The follow-up colonoscopy was performed in 8 patients at 7 to 10 d after the occurrence of ischemic colitis. Biopsy samples were subjected to real-time RT-PCR and immunohistochemistry to detect the expression of HIF-1 alpha and VEGF.
RESULTS: HIF-1 alpha and VEGF expression were found in the normal colon tissues by RT-PCR and immunohistochemistry. HIF-1 alpha and VEGF were overexpressed in the lesions of ischemic colitis. Overexpressed HIF-1 alpha and VEGF RNA quickly decreased to the normal level in the scar regions at 7 to 10 d after the occurrence of ischemic colitis.
CONCLUSION: Constant expression of HIF-1 alpha and VEGF in normal human colon tissue suggested that HIF-1 alpha and VEGF play an important role in maintaining tissue integrity. We confirmed the ischemic crisis in ischemic colitis at the molecular level, demonstrating overexpression of HIF-1 alpha and VEGF in ischemic lesions. These ischemic factors may play an important role in the pathophysiology of ischemic colitis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15770733      PMCID: PMC4305699          DOI: 10.3748/wjg.v11.i10.1535

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  23 in total

1.  HIF-1alpha is essential for myeloid cell-mediated inflammation.

Authors:  Thorsten Cramer; Yuji Yamanishi; Björn E Clausen; Irmgard Förster; Rafal Pawlinski; Nigel Mackman; Volker H Haase; Rudolf Jaenisch; Maripat Corr; Victor Nizet; Gary S Firestein; Hans Peter Gerber; Napoleone Ferrara; Randall S Johnson
Journal:  Cell       Date:  2003-03-07       Impact factor: 41.582

Review 2.  Diagnosis and management of intestinal ischaemic disorders.

Authors:  Jayaprakash Sreenarasimhaiah
Journal:  BMJ       Date:  2003-06-21

3.  A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation.

Authors:  G L Semenza; G L Wang
Journal:  Mol Cell Biol       Date:  1992-12       Impact factor: 4.272

4.  Reevaluation of clinical features of ischemic colitis. Analysis of 68 consecutive cases diagnosed by early colonoscopy.

Authors:  Y Habu; Y Tahashi; K Kiyota; K Matsumura; M Hirota; H Inokuchi; K Kawai
Journal:  Scand J Gastroenterol       Date:  1996-09       Impact factor: 2.423

5.  Ischaemic colitis.

Authors:  A Marston; M T Pheils; M L Thomas; B C Morson
Journal:  Gut       Date:  1966-02       Impact factor: 23.059

6.  Activation of hypoxia-inducible factor 1alpha: posttranscriptional regulation and conformational change by recruitment of the Arnt transcription factor.

Authors:  P J Kallio; I Pongratz; K Gradin; J McGuire; L Poellinger
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-27       Impact factor: 11.205

Review 7.  Ischaemic colitis.

Authors:  P H MacDonald
Journal:  Best Pract Res Clin Gastroenterol       Date:  2002-02       Impact factor: 3.043

8.  High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis.

Authors:  B Millauer; S Wizigmann-Voos; H Schnürch; R Martinez; N P Møller; W Risau; A Ullrich
Journal:  Cell       Date:  1993-03-26       Impact factor: 41.582

Review 9.  The vascular endothelial growth factor family of polypeptides.

Authors:  N Ferrara; K A Houck; L B Jakeman; J Winer; D W Leung
Journal:  J Cell Biochem       Date:  1991-11       Impact factor: 4.429

10.  Hypoxia-inducible factor 1-dependent induction of intestinal trefoil factor protects barrier function during hypoxia.

Authors:  G T Furuta; J R Turner; C T Taylor; R M Hershberg; K Comerford; S Narravula; D K Podolsky; S P Colgan
Journal:  J Exp Med       Date:  2001-05-07       Impact factor: 14.307

View more
  10 in total

Review 1.  Interactions between nitric oxide and hypoxia-inducible factor signaling pathways in inflammatory disease.

Authors:  Nels Olson; Albert van der Vliet
Journal:  Nitric Oxide       Date:  2011-01-01       Impact factor: 4.427

2.  Hypoxia-inducible factor 1-α in chronic gastrointestinal ischemia.

Authors:  Jihan Harki; Aria Sana; Désirée van Noord; Paul J van Diest; Petra van der Groep; Ernst J Kuipers; Leon M G Moons; Katharina Biermann; Eric T T L Tjwa
Journal:  Virchows Arch       Date:  2014-11-26       Impact factor: 4.064

3.  Mucosal protection by hypoxia-inducible factor prolyl hydroxylase inhibition.

Authors:  Andreas Robinson; Simon Keely; Jörn Karhausen; Mark E Gerich; Glenn T Furuta; Sean P Colgan
Journal:  Gastroenterology       Date:  2008-01       Impact factor: 22.682

4.  Elevation of vascular endothelial growth factor production and its effect on revascularization and function of graft islets in diabetic rats.

Authors:  Ying Cheng; Yong-Feng Liu; Jia-Lin Zhang; Tie-Min Li; Ning Zhao
Journal:  World J Gastroenterol       Date:  2007-05-28       Impact factor: 5.742

Review 5.  Reducing radiation-induced gastrointestinal toxicity - the role of the PHD/HIF axis.

Authors:  Monica M Olcina; Amato J Giaccia
Journal:  J Clin Invest       Date:  2016-08-22       Impact factor: 14.808

6.  VEGF 165 b, an antiangiogenic VEGF-A isoform, binds and inhibits bevacizumab treatment in experimental colorectal carcinoma: balance of pro- and antiangiogenic VEGF-A isoforms has implications for therapy.

Authors:  A H R Varey; E S Rennel; Y Qiu; H S Bevan; R M Perrin; S Raffy; A R Dixon; C Paraskeva; O Zaccheo; A B Hassan; S J Harper; D O Bates
Journal:  Br J Cancer       Date:  2008-03-18       Impact factor: 7.640

7.  Induction of CD36 and thrombospondin-1 in macrophages by hypoxia-inducible factor 1 and its relevance in the inflammatory process.

Authors:  Dolores Ortiz-Masià; Irene Díez; Sara Calatayud; Carlos Hernández; Jesús Cosín-Roger; Joaquín Hinojosa; Juan V Esplugues; María D Barrachina
Journal:  PLoS One       Date:  2012-10-31       Impact factor: 3.240

8.  Cellular turnover and expression of hypoxic-inducible factor in acute acalculous and calculous cholecystitis.

Authors:  Merja Vakkala; Jouko J Laurila; Juha Saarnio; Vesa Koivukangas; Hannu Syrjälä; Tuomo Karttunen; Ylermi Soini; Tero I Ala-Kokko
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

Review 9.  The tumour microenvironment links complement system dysregulation and hypoxic signalling.

Authors:  Monica M Olcina; Ryan K Kim; Stavros Melemenidis; Edward E Graves; Amato J Giaccia
Journal:  Br J Radiol       Date:  2018-05-15       Impact factor: 3.039

10.  Polydeoxyribonucleotide Exerts Therapeutic Effect by Increasing VEGF and Inhibiting Inflammatory Cytokines in Ischemic Colitis Rats.

Authors:  Sung-Eun Kim; Il-Gyu Ko; Jun-Jang Jin; Lakkyong Hwang; Chang-Ju Kim; Sang-Hoon Kim; Jin-Hee Han; Jung Won Jeon
Journal:  Biomed Res Int       Date:  2020-02-21       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.